Abiomed Impella RT-DAQ - Observational Study

Active, not recruitingOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

October 4, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions
Cardiogenic Shock
Interventions
OTHER

Data Acquisition

Develop algorithms for determining the cardiac output through the synchronous acquisition of hemodynamic data from the pulmonary artery catheter or other pressure sensors and Impella using a network module.

Trial Locations (5)

20132

IRCCS Ospedale San Raffaele, Milan

22763

Asklepios Klinik Altona, Hamburg

24105

UKSH Campus Kiel, Kiel

52074

Uniklinik RWTH Aachen, Aachen

Unknown

Universitätsspital Basel, Basel

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abiomed Inc.

INDUSTRY

NCT06308055 - Abiomed Impella RT-DAQ - Observational Study | Biotech Hunter | Biotech Hunter